KENNETH MUTHEE: Open Payments
NPI 1194442558 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 4 payments from 3 companies in 2025. Trend: 2023 $20 · 2024 $427 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| ABBVIE INC. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: UZEDY, VRAYLAR, INGREZZA.
Industry payments across MD — which companies pay providers there.
